Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Articles

The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma

Maha Ayyoub, Robert N. Taub, Mary-Louise Keohan, Mary Hesdorffer, Genevieve Metthez, Lorenzo Memeo, Mahesh Mansukhani, Hanina Hibshoosh, Charles S. Hesdorffer and Danila Valmori
Maha Ayyoub
1Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert N. Taub
2Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary-Louise Keohan
2Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Hesdorffer
2Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Genevieve Metthez
1Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorenzo Memeo
3Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahesh Mansukhani
3Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanina Hibshoosh
3Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles S. Hesdorffer
2Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danila Valmori
1Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published January 2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: to

AbstractFull-text HTMLPDF
Total000

Cited By

Article Information

Volume 4, Issue 1, pp.


Published By 
Cancer Research Institute
Print ISSN 
1424-9634
Online ISSN 
1424-9634
History 
  • Received May 19, 2004
  • Accepted June 16, 2004
  • Published first January 1, 2004.

Copyright & Usage 
Copyright © 2004 by Danila Valmori

Author Information

  1. Maha Ayyoub1,
  2. Robert N. Taub2,
  3. Mary-Louise Keohan2,
  4. Mary Hesdorffer2,
  5. Genevieve Metthez1,
  6. Lorenzo Memeo3,
  7. Mahesh Mansukhani3,
  8. Hanina Hibshoosh3,
  9. Charles S. Hesdorffer2 and
  10. Danila Valmori1
  1. 1Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
  2. 2Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
  3. 3Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY, USA
  1. Address correspondence to: Danila Valmori, Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, 650 West 168th Street, Black Building Room 20-09, New York, NY 10032, USA, Tel.: + 1 212 305 1962, Fax: + 1 212 305 7348, E-mail: dv2117{at}columbia.edu
  1. Communicated by: LJ Old

View Full Text
PreviousNext
Back to top
Cancer Immunity Archive: 4 (1)
January 2004
Volume 4, Issue 1
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma
Maha Ayyoub, Robert N. Taub, Mary-Louise Keohan, Mary Hesdorffer, Genevieve Metthez, Lorenzo Memeo, Mahesh Mansukhani, Hanina Hibshoosh, Charles S. Hesdorffer and Danila Valmori
Cancer Immun January 1 2004 (4) (1) 7;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma
Maha Ayyoub, Robert N. Taub, Mary-Louise Keohan, Mary Hesdorffer, Genevieve Metthez, Lorenzo Memeo, Mahesh Mansukhani, Hanina Hibshoosh, Charles S. Hesdorffer and Danila Valmori
Cancer Immun January 1 2004 (4) (1) 7;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and methods
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of dichotomy between CD8+ responses elicited by apoptotic and necrotic cells
  • Intraepithelial T cells and tumor-associated macrophages in ovarian cancer patients
  • BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement